HealthCare Sector in Focus: New Research on Arrhythmia, ZELTIQ, Medtronic, St. Jude Medical, and Varian Medical
NEW YORK, March 3, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Moments ago, Analysts Review released new research updates concerning several important developing situations including Arrhythmia (NYSEMKT: HRT), ZELTIQ (NASDAQ: ZLTQ), Medtronic (NYSE: MDT), St. Jude Medical (NYSE: STJ), and Varian Medical (NYSE: VAR). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
HRT Research Report: ( http://get.analystsreview.com/pdf/?c=Arrhythmia&d=03-Mar-2015&s=HRT ),
ZLTQ Research Report: ( http://get.analystsreview.com/pdf/?c=ZELTIQ&d=03-Mar-2015&s=ZLTQ ),
MDT Research Report: ( http://get.analystsreview.com/pdf/?c=Medtronic&d=03-Mar-2015&s=MDT ),
STJ Research Report: ( http://get.analystsreview.com/pdf/?c=St.%20Jude%20Medical&d=03-Mar-2015&s=STJ ),
VAR Research Report: ( http://get.analystsreview.com/pdf/?c=Varian%20Medical&d=03-Mar-2015&s=VAR ).
============
--
Analyst Update: Recognition, Upcoming Earnings, Appointment, Dividend, Launch and Approval
Reviewed by: Rohit Tuli, CFA®
The U.S. indices closed at record highs on Monday with Nasdaq Composite closing above 5,000 - a level not reached since 2000 - as tech stocks were boosted by deals in the sector. The tech-heavy index added 44.57 points, or 0.9%, to close at 5,008.10. Meanwhile, the S&P 500 added 12.89 points, or 0.6%, to reach its record high of 2,117.39. The Dow Jones Industrial Average also jumped 155.93 points, or 0.9%, to 18,288.63, making its fourth record-high close this year. The markets moved up despite economic reports pointing to a slowdown in manufacturing activity as well as consumer spending. European equities slipped amid concerns over the economic future of Greece. The Stoxx Europe 600 ended the day 0.2% lower, slipping off a near seven-year high. Asian stocks ended higher after China cut its benchmark lending and deposit rates on Saturday. Japan's Nikkei 225 index gained 0.2%, Hong Kong's Hang Seng index rose 0.3%, and the Shanghai Composite was up 1%.
Arrhythmia Research Technology, Inc. (Arrhythmia) announced the appointment of Mr. Derek T. Welch as the Company's CFO, effective January 1, 2015. Mr. Welch has been serving as the Company's principal financial officer and principal accounting officer since September 2013.
ZELTIQ Aesthetics, Inc. (ZELTIQ) plans to release its fourth quarter and full year 2014 financial results on March 3, 2015 after the market close, which will be followed by a conference call on the same day at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results.
Medtronic, Inc. (Medtronic) announced that it has received U.S. Food and Drug Administration (FDA) approval for VenaSeal(TM) closure system- a next-generation chronic venous insufficiency procedure with demonstrated safety and effectiveness.
St. Jude Medical, Inc.'s (St. Jude Medical) board of directors declared quarterly dividend to $0.29 per common share, payable on April 30, 2015, to shareholders of record on March 31, 2015. The Company also announced launch of the HALO U.S. IDE Trial to evaluate the safety and efficacy of the St. Jude Medical Masters HPTM Series 15mm mechanical heart valve, the smallest pediatric mechanical heart valve in the world.
Varian Medical Systems, Inc. (Varian Medical) announced that its Eclipse™ treatment planning software has been recognized as "Category Leader" in the 2014 "Best in KLAS: Software and Services Report" by KLAS - a research firm that specializes in monitoring and reporting on the performance of healthcare vendors.
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article